시장보고서

상품코드

1790326

세계의 소아 당뇨병 관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use (Homecare, Pediatric Clinics), By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 07월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소아당뇨병 관리 시장 개요

세계 소아당뇨병 관리 시장 규모는 2024년 55억 9,000만 달러로 평가되었습니다. 2033년에는 131억 1,000만 달러에 달하고, 2025-2033년 9.96%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 성장은 소아 및 청소년의 당뇨병, 특히 제1형 당뇨병의 전 세계 유병률 증가로 인해 효과적인 모니터링 및 치료 솔루션에 대한 수요가 크게 증가하고 있기 때문입니다.

혈당 모니터링(BGM), 연속 혈당 모니터링(CGM), 인슐린 전달 시스템의 기술 발전으로 정확성, 편의성, 순응도가 향상되어 소아에게 적합합니다. 전 세계적으로 1형 당뇨병은 여전히 소아에서 가장 흔한 질환이지만, 소아비만 증가, 앉아있는 생활습관, 식생활의 변화로 인해 저연령층에서 2형 당뇨병의 진단이 크게 증가하고 있습니다. 국제당뇨병연맹에 따르면, 2022년에는 20세 인구 중 약 152만 명이 당뇨병에 걸릴 것이라고 합니다. 이러한 높은 당뇨병 유병률은 상시 모니터링과 장기적인 질병 관리에 대한 수요를 증가시키고, 소아에 초점을 맞춘 당뇨병 관리 솔루션에 대한 수요를 증가시키고 있습니다. 소아 환자 그룹의 당뇨병을 다루기 위한 규제 지원과 이니셔티브 증가는 시장 성장을 더욱 촉진할 것입니다.

당뇨병 관리 기기의 기술 발전은 편안함, 사용 편의성, 실시간 통찰력이 질병 순응도에 필수적이기 때문에 시장 성장에 큰 영향을 미치고 있습니다. 소아 및 청소년에 특화된 소형, 저침습적, 사용하기 쉬운 기기 개발에 투자하는 기업이 늘고 있습니다. 튜브리스 인슐린 펌프, 센서 수명이 연장된 지속형 혈당 측정기(CGM), 스마트폰 연결 시스템 등 혁신적인 기술로 환자의 순응도와 보호자의 모니터링이 향상되고 있습니다. 이 기기들은 인슐린 투여를 자동화하고 예측 경고를 생성하여 저혈당 및 고혈당 위험을 최소화하고 유아와 보호자 모두의 부담을 덜어줍니다.

또한, 시장 업체들은 제품의 소형화 등 소아에 특화된 설계 기능의 투입에 주력하고 있으며, 이는 채택 확대에 더욱 기여하고 있습니다. 예를 들어, 2023년 7월 Tandem Diabetes Care의 소형 인슐린 펌프 Tandem Mobi는 아이폰 앱으로 제어할 수 있고 CGM과 호환되며 소아(6세 이상) 및 성인용 인슐린 펌프 Tandem Mobi가 FDA의 승인을 받았습니다. t : slim X2의 절반 크기로 Control IQ 자동화를 통합하고, 더 짧은 튜브와 원격 업데이트가 특징입니다.

지역 전망
소아 당뇨병 관리 시장 : 지역 변동 분석과 시장 점유율, 2024년 & 2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

시장 진출기업 분류
주요 기업 개요
- Medtronic
- Dexcom
- Abbott
- Tandem Diabetes Care
- Insulet Corporation
- Novo Nordisk
- Sanofi
- Eli Lilly and Company
- Roche Diabetes Care
- Ascensia Diabetes Care

LSH 25.08.20

Pediatric Diabetes Market Summary

The global pediatric diabetes management market size was estimated at USD 5.59 billion in 2024 and is projected to reach USD 13.11 billion by 2033, growing at a CAGR of 9.96% from 2025 to 2033. The growth of the market is attributed to the rising global prevalence of diabetes, particularly Type 1, among children and adolescents, which has significantly increased the demand for effective monitoring and treatment solutions.

Technological advancements in blood glucose monitoring (BGM), continuous glucose monitoring (CGM), and insulin delivery systems have improved accuracy, convenience, and compliance, making them more suitable for pediatric use. Globally, type 1 diabetes remains the most common form in children, but the rising incidence of childhood obesity, sedentary lifestyles, and poor dietary habits has led to a significant rise in type 2 diabetes diagnoses in younger age groups. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022. This high prevalence of diabetes is increasing demand for constant monitoring and long-term disease management, thereby contributing to demand for pediatric-focused diabetes care solutions. The increasing regulatory support and initiatives to address diabetes in pediatric patient groups further fuel the market growth.

Technological advancements in diabetes management devices have significantly influenced the market growth as comfort, usability, and real-time insights are crucial for disease adherence. Companies are increasingly investing in the development of compact, minimally invasive, and user-friendly devices that cater specifically to children and adolescents. Innovations such as tubeless insulin pumps, continuous glucose monitors (CGMs) with extended sensor life, and smartphone-connected systems have improved patient compliance and parental monitoring. These devices reduce the burden on both children and caregivers by automating insulin dosing and generating predictive alerts, minimizing the risks of hypoglycemia or hyperglycemia.

Additionally, market players are focusing on launching pediatric-specific design features, such as miniaturization of products, further contributing to their increasing adoption. For instance, in July 2023, Tandem Diabetes Care's miniature-sized insulin pump, Tandem Mobi, controllable via iPhone app and compatible with CGM, got FDA clearance for children (>=6 years) and adults. Half the size of t : slim X2, it integrates Control IQ automation, features shorter tubing, and remote updates.

Global Pediatric Diabetes Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pediatric diabetes management market report on the basis of product, technology, end-use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Blood Glucose Monitors (BGM)
Continuous Glucose Monitors (CGM)
Insulin Pumps
Insulin Pens
Insulin Syringes
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Connected Devices
Non-connected Devices
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
- General Hospitals
- Children Hospitals
Homecare
Pediatric Clinics
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- Kuwait
- UAE

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Purchased database.
1.5. GVR's internal database
1.6. Secondary sources
1.7. Third Party Perspective
1.8. Primary research
1.9. Details of primary research
1.10. Information or Data Analysis
1.11. Data analysis models
1.12. Market Formulation & Validation
1.13. Model Details
1.14. Commodity flow analysis (Model 1)
1.15. Approach 1: Commodity flow approach
1.16. Volume price analysis (Model 2)
1.17. Approach 2: Volume price analysis
1.18. List of Secondary Sources
1.19. List of Primary Sources
1.20. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pediatric Diabetes Management Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising incidence of diabetes in children and adolescents
  - 3.2.1.2. Technological advancements in diabetes management devices
  - 3.2.1.3. Increasing awareness and early diagnosis
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of certain diabetes management devices
- 3.2.3. Market Opportunities Analysis
  - 3.2.3.1. Rising preference toward advanced diabetes management devices
- 3.2.4. Market Challenges Analysis
  - 3.2.4.1. Caregiver burden and patient education challenges
3.3. Pediatric Diabetes Management Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. Pediatric Diabetes Management Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Pediatric Diabetes Management Market: Product Movement Analysis & Market Share, 2024 & 2033
4.3. Blood Glucose Monitors (BGM)
- 4.3.1. Blood Glucose Monitors (BGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Continuous Glucose Monitors (CGM)
- 4.4.1. Continuous Glucose Monitors (CGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Insulin Pumps
- 4.5.1. Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Insulin Pens
- 4.6.1. Insulin Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Insulin Syringes
- 4.7.1. Insulin Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pediatric Diabetes Management Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Pediatric Diabetes Management Market: Technology Movement Analysis & Market Share, 2024 & 2033
5.3. Connected Devices
- 5.3.1. Connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Non-connected Devices
- 5.4.1. Non-connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pediatric Diabetes Management Market: End-use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Pediatric Diabetes Management Market: End-use Movement Analysis & Market Share, 2024 & 2033
6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. General Hospitals
  - 6.3.2.1. General Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Children Hospitals
  - 6.3.3.1. Children Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Homecare
- 6.4.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Pediatric Clinics
- 6.5.1. Pediatric Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pediatric Diabetes Management Market: Regional Estimates & Trend Analysis by Product, Technology, End-Use

7.1. Regional Outlook
7.2. Pediatric Diabetes Management Market: Regional Movement Analysis & Market Share, 2024 & 2033
7.3. North America
- 7.3.1. North America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Scenario
  - 7.3.2.4. Reimbursement Scenario
  - 7.3.2.5. U.S. Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Scenario
  - 7.3.3.4. Reimbursement Scenario
  - 7.3.3.5. Canada Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Scenario
  - 7.3.4.4. Reimbursement Scenario
  - 7.3.4.5. Mexico Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Europe
- 7.4.1. Europe Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Scenario
  - 7.4.2.4. Reimbursement Scenario
  - 7.4.2.5. UK Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Scenario
  - 7.4.3.4. Reimbursement Scenario
  - 7.4.3.5. Germany Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Scenario
  - 7.4.4.4. Reimbursement Scenario
  - 7.4.4.5. France Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Scenario
  - 7.4.5.4. Reimbursement Scenario
  - 7.4.5.5. Italy Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Scenario
  - 7.4.6.4. Reimbursement Scenario
  - 7.4.6.5. Spain Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Scenario
  - 7.4.7.4. Reimbursement Scenario
  - 7.4.7.5. Denmark Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Scenario
  - 7.4.8.4. Reimbursement Scenario
  - 7.4.8.5. Sweden Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Scenario
  - 7.4.9.4. Reimbursement Scenario
  - 7.4.9.5. Norway Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Scenario
  - 7.5.2.4. Reimbursement Scenario
  - 7.5.2.5. Japan Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Scenario
  - 7.5.3.4. Reimbursement Scenario
  - 7.5.3.5. China Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Scenario
  - 7.5.4.4. Reimbursement Scenario
  - 7.5.4.5. India Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Scenario
  - 7.5.5.4. Reimbursement Scenario
  - 7.5.5.5. South Korea Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Scenario
  - 7.5.6.4. Reimbursement Scenario
  - 7.5.6.5. Australia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Scenario
  - 7.5.7.4. Reimbursement Scenario
  - 7.5.7.5. Thailand Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
- 7.6.1. Latin America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Scenario
  - 7.6.2.4. Reimbursement Scenario
  - 7.6.2.5. Brazil Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Scenario
  - 7.6.3.4. Reimbursement Scenario
  - 7.6.3.5. Argentina Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Middle East & Africa
- 7.7.1. Middle East & Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Scenario
  - 7.7.2.4. Reimbursement Scenario
  - 7.7.2.5. South Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Scenario
  - 7.7.3.4. Reimbursement Scenario
  - 7.7.3.5. Saudi Arabia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Scenario
  - 7.7.4.4. Reimbursement Scenario
  - 7.7.4.5. UAE Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Scenario
  - 7.7.5.4. Reimbursement Scenario
  - 7.7.5.5. Kuwait Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization
8.2. Key Company Profiles
- 8.2.1. Medtronic
  - 8.2.1.1. Company Overview
  - 8.2.1.2. Financial Performance
  - 8.2.1.3. Product Benchmarking
  - 8.2.1.4. Strategic Initiatives
- 8.2.2. Dexcom
  - 8.2.2.1. Company Overview
  - 8.2.2.2. Financial Performance
  - 8.2.2.3. Product Benchmarking
  - 8.2.2.4. Strategic Initiatives
- 8.2.3. Abbott
  - 8.2.3.1. Company Overview
  - 8.2.3.2. Financial Performance
  - 8.2.3.3. Product Benchmarking
  - 8.2.3.4. Strategic Initiatives
- 8.2.4. Tandem Diabetes Care
  - 8.2.4.1. Company Overview
  - 8.2.4.2. Financial Performance
  - 8.2.4.3. Product Benchmarking
  - 8.2.4.4. Strategic Initiatives
- 8.2.5. Insulet Corporation
  - 8.2.5.1. Company Overview
  - 8.2.5.2. Financial Performance
  - 8.2.5.3. Product Benchmarking
  - 8.2.5.4. Strategic Initiatives
- 8.2.6. Novo Nordisk
  - 8.2.6.1. Company Overview
  - 8.2.6.2. Financial Performance
  - 8.2.6.3. Product Benchmarking
  - 8.2.6.4. Strategic Initiatives
- 8.2.7. Sanofi
  - 8.2.7.1. Company Overview
  - 8.2.7.2. Financial Performance
  - 8.2.7.3. Product Benchmarking
  - 8.2.7.4. Strategic Initiatives
- 8.2.8. Eli Lilly and Company
  - 8.2.8.1. Company Overview
  - 8.2.8.2. Financial Performance
  - 8.2.8.3. Product Benchmarking
  - 8.2.8.4. Strategic Initiatives
- 8.2.9. Roche Diabetes Care
  - 8.2.9.1. Company Overview
  - 8.2.9.2. Financial Performance
  - 8.2.9.3. Product Benchmarking
  - 8.2.9.4. Strategic Initiatives
- 8.2.10. Ascensia Diabetes Care
  - 8.2.10.1. Company Overview
  - 8.2.10.2. Financial Performance
  - 8.2.10.3. Product Benchmarking
  - 8.2.10.4. Strategic Initiatives

세계의 소아 당뇨병 관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use (Homecare, Pediatric Clinics), By Region, And Segment Forecasts, 2025 - 2033

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 소아 당뇨병 관리 시장 변수, 동향 및 범위

제4장 소아 당뇨병 관리 시장 : 제품별, 추정 및 동향 분석

제5장 소아 당뇨병 관리 시장 : 기술별, 추정 및 동향 분석

제6장 소아 당뇨병 관리 시장 : 최종 용도별, 추정 및 동향 분석

제7장 소아 당뇨병 관리 시장 : 제품, 기술, 최종 용도에 의한 지역별, 추정 및 동향 분석